Literature DB >> 20560078

Measuring minimum inhibitory concentrations in mycobacteria.

Frederick A Sirgel1, Ian J F Wiid, Paul D van Helden.   

Abstract

An agar dilution method for measuring minimum inhibitory concentrations (MICs) of Mycobacterium tuberculosis, based on the method of proportion, is described. Mycobacterium strains are grown on Middlebrook 7H10 (or 7H11) agar medium with twofold serially diluted drug concentrations in order to determine specific inhibitory values. The proportion of bacilli resistant to a given drug is determined by comparing the number of colony-forming units (CFU) on a drug-free control with those growing in the presence of drug within a specific concentration range. The MIC is defined as the lowest drug concentration that inhibits growth of more than 99% of a bacterial population of M. tuberculosis on solid Middlebrook medium within 21 days of incubation at 37 degrees C. The proportion method, the absolute concentration method, and the resistant ratio method have traditionally been used as standard procedures for antimycobacterial drug-susceptibility testing (DST), and reference data are mainly based on these methods. DST concepts and alternative procedures that have been adopted for DST are also briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20560078     DOI: 10.1007/978-1-59745-207-6_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Predominant Mycobacterium tuberculosis Families and High Rates of Recent Transmission among New Cases Are Not Associated with Primary Multidrug Resistance in Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Bouke C de Jong; Tomotada Iwamoto; Kentaro Arikawa; Patrick Van der Stuyft; Stefan Niemann; Matthias Merker; Cécile Uwizeye; Carlos Seas; Leen Rigouts
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

2.  Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis.

Authors:  Sreevalli Sharma; Ekaterina Gelman; Chandan Narayan; Deepa Bhattacharjee; Vijayashree Achar; Vaishali Humnabadkar; V Balasubramanian; Vasanthi Ramachandran; Neeraj Dhar; Neela Dinesh
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

3.  Malachite green interferes with postantibiotic recovery of mycobacteria.

Authors:  Ekaterina Gelman; John D McKinney; Neeraj Dhar
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

4.  Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates.

Authors:  Kamal Singh; Swati Sharma; Tuhina Banerjee; Ankush Gupta; Shampa Anupurba
Journal:  BMC Microbiol       Date:  2022-10-03       Impact factor: 4.465

Review 5.  Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.

Authors:  Elisea Avalos; Donald Catanzaro; Antonino Catanzaro; Theodore Ganiats; Stephanie Brodine; John Alcaraz; Timothy Rodwell
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents.

Authors:  Edward A Kesicki; Mai A Bailey; Yulia Ovechkina; Julie V Early; Torey Alling; Julie Bowman; Edison S Zuniga; Suryakanta Dalai; Naresh Kumar; Thierry Masquelin; Philip A Hipskind; Joshua O Odingo; Tanya Parish
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

7.  Imidazoles Induce Reactive Oxygen Species in Mycobacterium tuberculosis Which Is Not Associated with Cell Death.

Authors:  Heather A Howell Wescott; David M Roberts; Christian L Allebach; Rachel Kokoczka; Tanya Parish
Journal:  ACS Omega       Date:  2017-01-05

8.  Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis.

Authors:  Michael W Mullowney; Chang Hwa Hwang; Andrew G Newsome; Xiaomei Wei; Urszula Tanouye; Baojie Wan; Skylar Carlson; Nanthida Joy Barranis; EoghainínÓ hAinmhire; Wei-Lun Chen; Kalyanaraman Krishnamoorthy; John White; Rachel Blair; Hyunwoo Lee; Joanna E Burdette; Pradipsinh K Rathod; Tanya Parish; Sanghyun Cho; Scott G Franzblau; Brian T Murphy
Journal:  ACS Infect Dis       Date:  2015-03-11       Impact factor: 5.084

9.  Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis.

Authors:  Thomas R Ioerger; Theresa O'Malley; Reiling Liao; Kristine M Guinn; Mark J Hickey; Nilofar Mohaideen; Kenan C Murphy; Helena I M Boshoff; Valerie Mizrahi; Eric J Rubin; Christopher M Sassetti; Clifton E Barry; David R Sherman; Tanya Parish; James C Sacchettini
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.

Authors:  Andrés Palencia; Xianfeng Li; Wei Bu; Wai Choi; Charles Z Ding; Eric E Easom; Lisa Feng; Vincent Hernandez; Paul Houston; Liang Liu; Maliwan Meewan; Manisha Mohan; Fernando L Rock; Holly Sexton; Suoming Zhang; Yasheen Zhou; Baojie Wan; Yuehong Wang; Scott G Franzblau; Lisa Woolhiser; Veronica Gruppo; Anne J Lenaerts; Theresa O'Malley; Tanya Parish; Christopher B Cooper; M Gerard Waters; Zhenkun Ma; Thomas R Ioerger; James C Sacchettini; Joaquín Rullas; Iñigo Angulo-Barturen; Esther Pérez-Herrán; Alfonso Mendoza; David Barros; Stephen Cusack; Jacob J Plattner; M R K Alley
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.